Schizophrenia: From epidemiology to rehabilitation

Clinical Practice and Epidemiology in Mental Health

Volumn 8, Issue , 2012, Pages 52-66

  Mura, Gioia ^a   Petretto, Donatella Rita ^b   Bhat, Krishna M ^c   Carta, Mauro Giovanni ^a  

^a DEPARTMENT OF RADIOLOGY   (Italy)

^b UNIVERSITY OF CAGLIARI   (Italy)

^c UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

Epidemiology; Etiology; Functioning; Genetics; Schizophrenia

Indexed keywords

AUTOIMMUNE DISEASE; COGNITIVE DEFECT; COGNITIVE THERAPY; COPING BEHAVIOR; DISEASE COURSE; DRUG DEPENDENCE; ENVIRONMENTAL STRESS; GENDER; GENETICS; HUMAN; INCIDENCE; INTELLIGENCE QUOTIENT; MIGRATION; MORBIDITY; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PATERNAL AGE; PREVALENCE; REVIEW; RISK FACTOR; SCHIZOPHRENIA; SOCIAL ADAPTATION; SOCIAL CLASS; URBAN AREA;

EID: 84884211481     PISSN: None     EISSN: 17450179     Source Type: Journal    
DOI: 10.2174/1745017901208010052     Document Type: Review

References (172)

1. Cooper JE, Kendall RE, Gurland BJ, et al. Psychiatric diagnosis in New York and London: A comparative study of mental hospital admissions. Institute of Psychiatry, Maudsley Monographs, No 20. London, UK: Oxford University Press 1972.
2. Wing JK, Birley JLT, Cooper JE, et al. Reliability of a procedure for measuring and classifying "present psychiatric state". Br J Psychiatry 1967; 113: 499-515.
3. Feighner JP, Robins F, Guze SB, et al. Diagnostic criteria for use in psychiatric research. Arch Gen Psychiatry 1972; 26: 57-63.
4. Wing J, Nixon J. Discriminating symptoms in schizophrenia. A report from the international pilot study of schizophrenia. Arch Gen Psychiatry 1975; 32(7): 853-9.
5. Sartorius N, Jablensky A, Korten A, et al. Early manifestations and first-contact incidence of schizophrenia in different cultures. A preliminary report on the initial evaluation phase of the WHO Collaborative Study on determinants of outcome of severe mental disorders. Psychol Med 1986; 16(4): 909-28.
6. Jablensky A, Sartorius N, Ernberg G, et al. Schizophrenia: Manifestation, incidence and course in different cultures. A World Health Organization ten-country study. Psychol Med Monogr Suppl 1992; 20: 1-97.
7. Saha S, Chant D, Welham J, McGrath J. A systematic review of the prevalence of schizophrenia. PLoS Med 2005; 2(5): e141 .
8. Jablensky A, Sartorius N, Ernberg G, et al. Schizophrenia: Manifestation, incidence and course in different cultures. A World Health Organization ten-country study. Psychol Med Monogr Suppl 1992; 20: 1-97.
9. McGrath J, Saha S, Welham J, et al. A systematic review of the incidence of schizophrenia: The distribution of rates and the influence of sex, urbanicity, migrant status and methodology. BMC Med 2004; 2:13.
10. Aleman A, Kahn RS, Selten JP. Sex differences in the risk of schizophrenia: Evidence from meta-analysis. Arch Gen Psychiatry 2003; 60: 565-71. (Pubitemid 36682313)
11. Andreasen NC, Nasrallah HA, Dunn V, et al. Structural abnormalities in the frontal system in schizophrenia: a magnetic resonance imaging study. Arch Gen Psychiatry 1986; 43: 136-44. (Pubitemid 16163532)
12. Feinberg I. Schizophrenia and late maturational brain changes in man. Psychopharmacol Bull 1982; 18: 229-31.
13. Weinberger DR. Implications of normal brain development for the pathogenesis of schizophrenia. Arch Gen Psychiatry 1987; 44: 660-9. (Pubitemid 17099795)
14. Torrey EF, Miller J, Rawlings R, Yolken RH. Seasonality of births in schizophrenia and bipolar disorders: a review of the literature. Schizophr Res 1997; 28: 1-38. (Pubitemid 27522788)
15. Carriòn-Baralt JR, Fuentes-Rivera Z, Schmeidler J, Silverman JM. A case-control study of the seasonality effects on schizophrenic births on a tropical island. Schizophr Res 2004; 71(1): 145-53. (Pubitemid 39209484)
16. Ellman LM, Yolken RH, Buka SL, Torrey EF, Cannon TD. Cognitive functioning prior to the onset of psychosis: the role of fetal exposure to serologically determined influenza infection. Biol Psychiatry 2009; 65(12): 1040-7.
17. Cannon M, Jones PB, Murray RM. Obstetric complications and schizophrenia: historical and meta-analytic review. Am J Psychiatry 2002; 159: 1080-92. (Pubitemid 34743246)
18. Byrne M, Agerbo E, Bennedsen B, Eaton WW, Mortensen PB. Obstetric conditions and risk of first admission with schizophrenia: a Danish national register based study. Schizophr Res 2007; 97: 51-9. (Pubitemid 350088389)
19. Zammit S, Odd D, Horwood J, et al. Investigating whether adverse prenatal and perinatal events are associated with non-clinical psychotic symptoms at age 12 years in the ALSPAC birth cohort. Psychol Med 2009; 39: 1457-67.
20. Yolken RH, Bachmann S, Rouslanova I, et al. Antibodies to Toxoplasma gondii in individuals with first-episode schizophrenia. Clin Infec Dis 2001; 32: 842-4. (Pubitemid 32221950)
21. Yolken RH, Dickerson FB, Fuller Torrey E. Toxoplasma and schizophrenia. Parasite Immunol 2009; 31(11): 706-15.
22. Henriquez SA, Brett R, Alexander J, Pratt J, Roberts CW. Neuropsychiatric disease and Toxoplasma gondii infection. Neuroimmnomodulation 2009; 16(2): 122-33.
23. da Silva RC, Langoni H. Toxoplasma gondii: host-parasite interaction and behavior manipulation. Parasitol Res 2009; 105(4): 893-8.
24. Niemi LT, Suvisaari JM, Tuulio-Henriksson A, Lonnqvist JK. Childhood developmental abnormalities in schizophrenia: evidence from high-risk studies. Schizophr Res 2003; 60(2-3): 239-58. (Pubitemid 36184713)
25. Reichenberg A, Caspi A, Harrington H, et al. Static and dynamic deficits in childhood preceding adult schizophrenia: a 30-year study. Am J Psychiatry 2010; 167(2): 160-9.
26. Gregory I. An analysis of family data on 1000 patients admitted to a Canadian mental hospital. Acta Genet Stat Med 1959; 9: 54-96.
27. Petersen L, Mortensen PB, Pedersen CB. Paternal age at birth of first child and risk of schizophrenia. Am J Psychiatry 2011; 168(1): 82-8.
28. Perrin M, Harlap S, Kleinhaus K, et al. Older paternal age strongly increases the morbidity for schizophrenia in sisters of affected females. Am J Med Genet B Neuropsychiatr Genet 2010; 153B(7): 1329-35.
29. Li X, Sundquist J, Sundquist K. Age-specific familial risk of psychotic disorders and schizophrenia: a nation-wide epidemiological study from Sweden. Schizophr Res 2007; 97(1-3): 43-50. (Pubitemid 350088410)
30. Hubert A, Szoke A, Leboyer M, Schurhoff F. Influence of paternal age in schizophrenia. Encephale 2011; 37(3): 199-206.
31. Torrey EF, Buka S, Cannon TD, et al. Paternal age as a risk factor for schizophrenia: how important is it? Schizophr Res 2009; 114 (1-3): 1-5.
32. Malaspina D, Harlap S, Fenning S, et al. Advancing paternal age and the risk of schizophrenia. Arch Gen Psychiatry 2001; 58:361.
33. Sipos A, Rasmussen F, Harrison G, et al. Paternal age and schizophrenia: a population based cohort study. BMJ 2004; 329 (7474): 1070.
34. Perrin MC, Brown AS, Malaspina D. Aberrant epigenetic regulation could explain the relationship of paternal age to schizophrenia. Schizophr Bull 2007; 33: 1270-3. (Pubitemid 350022778)
35. Lee H, Malaspina D, Ahn H, et al. Paternal age related schizophrenia (PARS): Latent subgroups detected by K-means clustering analysis. Schizophr Res 2011; 128(1-3): 143-9.
36. Torrey EF, Yolken RH. The schizophrenia-rheumatoid arthritis connection: infection, immune, or both? Brain Behav Immun 2001; 15(4): 401-10.
37. Othman SS, Abdul Kadir K, Hassan J, et al. High prevalence of thyroid function test abnormalities in chronic schizophrenia. Aust N Z J Psychiatry 1994; 28(4): 620-4.
38. Hardoy MC, Cadeddu M, Serra A, et al. A pattern of cerebral perfusion anomalies between major depressive disorder and Hashimoto thyroiditis. BMC Psychiatry 2011; 11(1): 148.
39. Eaton WW, Byrne M, Ewald H, et al. Association of schizophrenia and autoimmune diseases: linkage of Danish national registers. Am J Psychiatry 2006; 163(3): 521-8. (Pubitemid 44469397)
40. Kalaydjian AE, Eaton W, Cascella N, Fasano A. The gluten connection: the association between schizophrenia and celiac disease. Acta Psychiatr Scand 2006; 113: 82-90. (Pubitemid 43340901)
41. Schmitt A, Leonardi-Essmann F, Durrenberger PF, et al. Regulation of immune-modulatory genes in left superior temporal cortex of schizophrenia patients: a genome-wide microarray study. World J Biol Psychiatry 2011; 12: 201-15.
42. Odegaard O. Emigration and insanity. Acta Psychiatr Neurol Scand Suppl 1932; 4: 1-206.
43. Carta MG, Bernal M, Hardoy MC, Haro-Abad JM, and the "Report on Mental Health in Europe" working group. Migration and mental health in Europe (the state of the mental health in Europe working group: appendix 1). Clin Pract Epidemiol Ment Health 2005; 1: 13.
44. Murray RM, Hutchinson G. Psychosis in migrants: the striking example of African-Carribean resident in England: In Gattaz WF, Hafner H, Eds.Search for the causes of Schizophrenia vol 4: Balance of the Century. Darmastadt, Germany: Steinkopff/Springer 1999; pp. 129-140.
45. Selten JP, Veen N, Feller W, et al. Incidence of psychotic disorders in immigrant groups to the Netherlands. Br J Psychiatry 2003; 182: 117-22.
46. Selten JP, Slaets JP, Kahn RS. Schizophrenia in Surinamese and Dutch Antillean immigrants in the Netherlands: evidence of an increased incidence. Psychol Med 1997; 27: 807-11. (Pubitemid 27332168)
47. Cantor-Graae E, Pedersen CB, McNeil TF, Mortensen PB. Migration as a risk factor for schizophrenia: a Danish population-based cohort study. Br J Psychiatry 2003; 182: 117-22. (Pubitemid 36177233)
48. Cooper B. Schizophrenia, social class and immigrant status: the epidemiological evidence. Epidemiol Psychiatr Soc 2005; 14: 137-44. (Pubitemid 41597507)
49. Hjern A, Wicks S, Dalman C. Social adversity contributes to high morbidity in psychosis in immigrants-a national cohort study in two generation of Swedish residents. Psychol Med 2004; 34: 1025-33. (Pubitemid 39199972)
50. Zolkowska K, Cantor-Grae E, McNeil TF. Increased rates of psychosis among immigrants to Sweden: is migration a risk factor for psychosis? Psychol Med 2001; 31: 669-78. (Pubitemid 32421968)
51. Cochrane R, Bal SS. Migration and schizophrenia: an examination of five hypotheses. Soc Psychiatry 1987; 22: 181-91.
52. Bourque F, van der Ven E, Malla A. A meta-analysis of the risk for psychotic disorders among first and second-generation immigrants. Psychol Med 2011; 41: 897-910.
53. Cantor-Graae E, Selten JP. Schizophrenia and migration: A metaanalysis and review. Am J Psychiatry 2005; 162: 12-24.
54. Pedersen CB, Mortensen PB, Cantor-Graae E. Do risk factors for schizophrenia predispose to emigration? Schizophr Res 2011; 127: 229-34.
55. van Os J, McGuffin P. Can the social environment cause schizophrenia? Br J Psychiatry 2003; 182: 291-2. (Pubitemid 36408278)
56. Boydell J, van Os J, McKenzie K, et al. Incidence of schizophrenia in ethnic minorities in London: ecological study into interactions with environment. Br Med J 2001; 323: 1-4.
57. Selten JP, Cantor-Graae E, Kahn RS. Migration and schizophrenia. Curr Opin Psychiatry. 2007; 20: 111-5. (Pubitemid 46215415)
58. Fatemi SH, Folsom TD. The neurodevelopmental hypothesis of schizophrenia, revisited. Schizophr Bull 2009; 35: 528-48.
59. Selten JP, Hoek HW. Does misdiagnosis explain the schizophrenia epidemic among immigrants from developing countries to Western Europe? Soc Psychiatry Psychiatr Epidemiol 2008; 43(12): 937-9.
60. Haasen C, Yagdiran O, Mass R. Differences between psychopathological evaluation in German and Turkish language of Turkish immigrants. Nervenartz 2000; 71(11): 901-5.
61. Casadio P, Fernandes C, Murray RM, Di Forti M. Cannabis use in young people: the risk for schizophrenia. Neurosci Biobehav Rev 2011; 35: 1779-87.
62. Zammit S, Allebeck P, Andreasson S, Lundberg I, Lewis G. Selfreported cannabis use as a risk factor for schizophrenia in Swedish conscripts of 1969: historical cohort study. BMJ 2002; 325(7374): 1199.
63. Dragt S, Nieman DH, Shultze-Lutter F, et al. Cannabis use and age of onset of symptoms in subjects at clinical high risk for psychosis. Acta Psychiatr Scand 2012; 125(1): 45-53.
64. Swadi H, Bobier C. Substance use disorder comorbidity among inpatient youths with clinical disorder. Aust N Z J Psychiatry 2003; 37(3): 294-8. (Pubitemid 36833759)
65. Weiser M, Noy S. Interpreting the association between cannabis use and increased risk for schizophrenia. Dialogues Clin Neurosci 2005; 7(1): 81-5. Review. (Pubitemid 40545559)
66. Costas J, Sanjùan J, Ramos-Rìos R, et al. Interaction between COMT haplotypes and cannabis in schizophrenia: a case-only study in two samples from Spain. Schizophr Res 2011; 127: 22-7.
67. Farris RE, Dunham HW. Mental disorders in Urban Areas. Chicago: University of Chicago Press 1939.
68. McGee R, Feehan M, Williams S, et al. DSM III disorders in a large sample of adolescents. J Am Acad Child Adolesc Psychiatry 1990; 29: 611-9. (Pubitemid 20235349)
69. Marcelis M, Takei N, van Os J. Urbanization and risk for schizophrenia: does the effect operate before or around the time of illness onset? Psychol Med 1999; 29(5): 1197-203. (Pubitemid 29469309)
70. Pedersen CB, Mortensen PB. Evidence of a dose-response relationship between urbanicity during upbringing and schizophrenia risk. Arch Gen Psychiatry 2001; 58(11): 1039-46. (Pubitemid 33051829)
71. Marcelis M, Navarro Mateu F, et al. Urbanization and psychosis: a study of 1942-1978 birth cohorts in the Netherlands. Psychol Med 1998; 28(4): 871-9. (Pubitemid 28393565)
72. Haukka J, Suvisaari J, Varilo T, Lonnqvist J. Regional variation in the incidence of schizophrenia in Finland: a study of birth cohorts born from 1950 to 1969. Psychol Med 2001; 31(6): 1045-53. (Pubitemid 32733962)
73. Mortensen PB. Why is the risk of schizophrenia greater in cities than in the country? Ugeskr Laeger 2001; 163: 4717-20.
74. vanOs J, Pedersen CB, Mortensen PB. Confirmation of synergy between urbanicity and familial liability in the causation of psychosis. Am J Psychiatry 2004; 161 (12): 2312-4. (Pubitemid 39587300)
75. Fox JW. Social class, mental illness, and social mobility: the social selection-drift hypothesis for serious mental illness. J Health Soc Behav 1990; 31: 344-53.
76. Jones PB, Bebbington P, Foerster A, et al. Premorbid social underachievement in schizophrenia. Results from the Camberwell Collaborative Psychosis Study. Br J Psychiatry 1993; 162: 65-71. (Pubitemid 23017016)
77. Yang J, Visscher PM, Wray NR. Sporadic cases are the norm for complex disease. Eur J Hum Genet 2010; 18(9): 1039-43.
78. Cardno AG, Gottesman I. Twin studies of schizophrenia: from bow-and-arrow concordance to Star Wars Mx and functional genomics. Am J Med Genet 2000; 97: 12.
79. Sullivan PF, Kendler KS, Neale MC. Schizophrenia as a complex trait: evidence from a meta-analysis of twins studies. Arch Gen Psychiatry 2003; 60(12): 1187-92. (Pubitemid 37494071)
80. Gottesman II, Bertelsen A. Confirming unexpressed genotypes for schizophrenia. Risk in the offspring of Fischer's Danish identical and fraternal discordant twins. Arch Gen Psychiatry 1989; 46(10): 867-72. (Pubitemid 19259531)
81. Kringlen E, Cramer G. Offspring of monozygotic twins discordant for schizophrenia. Arch Gen Psychiatry 1989; 46(10): 873-7. (Pubitemid 19259532)
82. Kendler KS, Gruenberg AM, Strauss JS. An independent analysis of the Copenhagen sample of the Danish adoption study of schizophrenia. II. The relationship between schizotypal personality disorder and schizophrenia. Arch Gen Psychiatry 1981; 38(9): 982-4. (Pubitemid 11061224)
83. Itokawa M, Arinami T, Toru M. Advanced research on dopamine signalling to develop drugs for the treatment of mental disorders: Ser311Cys polymorphisms of the dopamine D2-receptor gene and schizophrenia. J Pharmacol Sci 2010; 114: 1-5.
84. Williams HJ, Owen MJ, O'Donovan MC. Is COMT a susceptibility gene for schizophrenia? Schizophr Bull 2007; 33: 635-41. (Pubitemid 47343721)
85. Bitsios P, Roussos P. Tolcapone, COMT polymorphisms and pharmacogenomic treatment of schizophrenia. Pharmacogenomics 2011; 12: 559-66.
86. Costas J, Sanjuan J, Ramos-Rios R, et al. Interaction between COMT haplotypes and cannabis in schizophrenia: a case-only study in two samples from Spain. Schizophr Res 2011; 127: 22-7.
87. Suarez BK, Duan J, Sanders AR, et al. Genomewide linkage scan of 409 European-ancestry and African American families with schizophrenia: suggestive evidence of linkage at 8p23.3-p21.2 and 11p13.1-q14.1 in the combined sample. Am J Hum Genet 2006; 78: 315-33. (Pubitemid 43157570)
88. Faraone SV, Skol AD, Tsuang DW, et al. Genome scan of schizophrenia families in a large Veterans Affairs Cooperative Study sample: evidence for linkage to 18p11.32 and for racial heterogeneity on chromosomes 6 and 14. Am J Genet B Neuropsychiatr Genet 2005; 139B: 91-100. (Pubitemid 41552305)
89. Tabarés-Seisdedos R, Rubenstein JL. Chromosome 8p as a potential hub for developmental neuropsychiatric disorders: implications for schizophrenia, autism and cancer. Mol Psychiatry 2009; 14(6): 563-89.
90. Mowry BJ, Holmans PA, Pulver AE, et al. Multicenter linkage study of schizophrenia loci on chromosome 22q. Mol Psychiatry 2004; 9(8): 784-95. (Pubitemid 39107967)
91. Collins AL, Kim Y, Sklar P; International Schizophrenia Consortium, O'Donevan MC, Sullivan PF. Hypothesis-driven candidate genes for schizophrenia compared to genome-wide association studies. Psychol Med 2011; 19: 1-9.
92. International Schizophrenia Consortium. Purcell SM, Wray NR, Stone JL, et al. Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature 2009; 460 (7256): 748-52.
93. Rietschel M, Mattheisen M, Degenhardt F, et al. Association between genetic variation in a region on chromosome 11 and schizophrenia in large samples from Europe. Mol Psychiatry 2011 [Epub ahead of print].
94. Greenwood TA, Lazzeroni LC, Murray SS, et al. Analysis of 94 candidate genes and 12 endophenotypes for schizophrenia from the Consortium on the Genetics of Schizophrenia. Am J Psychiatry 2011; 168(9): 930-46.
95. Holmans PA, Riley B, Pulver AE,, et al. Genomewide linkage scan of schizophrenia in a large multicentre pedigree sample using single nucleotide polymorphisms. Mol Psychiatry 2009; 14(8): 786-95.
96. Fallin MD, Lasseter VK, Liu Y, et al. Linkage and association on 8p21.2-p21.1 in schizophrenia. Am J Med Genet B Neuropsychiatr Genet 2011; 156: 188-97.
97. Levinson DF, Duan J, Oh S, et al. Copy number variants in schizophrenia: confirmation of five previous findings and new evidence for 3q29 microdeletions and VIPR2 duplications. Am J Psychiatry 2011; 168: 302-16.
98. Ott J, Macciardi F, Shen Y, et al. A pilot study on schizophrenia in Sardinia. Hum Hered 2010; 70: 92-6.
99. Stefansson H, Ophoff RA, Steinberg S, et al. Common variants conferring risk of schizophrenia. Nature 2009; 460: 744-7.
100. O'Donovan MC, Craddock N, Norton N, et al. Identification of loci associated with schizophrenia by genome-wide association and follow- up. Nat Genet 2008; 40: 1053-5.
101. Zubin J, Magaziner J, Steinhauer SR. The metamorphosis of schizophrenia: from chronicity to vulnerability. Psychol Med 1983; 13: 551-71. (Pubitemid 13019021)
102. Bleuler M. The schizophrenic disorders: long term patient and family studies. New Haven: Yale University Press 1978.
103. Harding CM, Brooks GW, Ashikaga T, et al. The Vermont study of persons with severe mental illness. Long-term outcome of subjects who retrospectively met DSM-IV criteria for schizophrenia. Am J Psychiatry 1987; 144: 727-35. (Pubitemid 17086851)
104. Ciompi L. The natural history of schizophrenia in the long-term. Br J Psychiatry 1980; 136: 413-20.
105. L. The dynamics of complex biological psychosocial systems-four fundamental psychobiological mediators in the long-term evolution of schizophrenia. Br J Psychiatry 1989; 155 (Suppl 5): 15-21. (Pubitemid 19193202)
106. Zubin J, Spring B. Vulnerability- a new view of schizophrenia. J Abnorm Psychol 1977; 103-26.
107. Neuechterlein KH, Dawson ME. A heuristic vulnerability/stress model of schizophrenia episodes. Schizophr Bull 1984; 10(2): 300-12.
108. Brown GW, Birley JL. Crises and life changes and the onset of schizophrenia. J Health Soc Behav 1968; 9: 203-14.
109. Leff JP, Hirsch SR, Gaind R, Rohde PD, Stevens BS. Life events and maintenance therapy in schizophrenic relapse. Br J Psychiatry 1973; 123: 659-60.
110. Grace AA. Dopamine system dysregulation by the ventral subiculum as the common pathophysiological basis for schizophrenia psychosis, psychostimulant abuse, and stress. Neurotox Res 2010; 18: 367-76.
111. Corcoran C, Gallitano A, Leitman D, Malaspina D. The neurobiology of the stress cascade and its potential relevance for schizophrenia. J Psychiatr Pract 2001; 7: 3-14.
112. Leff J, Vaughn C. Expressed emotion. Hosp Community Psychiatry 1987; 38(10): 1117-9.
113. Goldstein MJ. Family factors that antedate the onset of schizophrenia and related disorders: the results of a fifteen year prospective longitudinal study. Acta Psychiatr Scand 1985; 71: 7-18. (Pubitemid 16193462)
114. Goldstein MJ. Psychosocial issues. Schizophr Bull 1987; 13(1): 157-71
115. Nuechterlein KH, Dawson ME, Ventura J, et al. The vulnerability/ stress model of schizophrenic relapse: a longitudinal study. Acta Psychiatr Scand Suppl 1994; 382: 58-64. (Pubitemid 24199715)
116. Meneghelli A, Alpi A, Pafumi N, et al. Expressed emotion in firstepisode schizophrenia and ultra high-risk patients: results from the Programma2000 (Milan, Italy). Psychiatry Res 2011; 189 (3): 331-8.
117. McCreadie RG, Robertson LJ, Hall DJ, Berry I. The Nithsdale schizophrenia survey. XI: Relatives'expressed emotion. Stability over five years and its relation to relapse. Br J Psychiatry 1993; 162: 393-7. (Pubitemid 23070205)
118. Hafner H, Maurer K, Loffler W, et al. The epidemiology of early schizophrenia. Influence of age and gender on onset and early course. Br J Psychiatry Suppl 1994; 23: 29-38. (Pubitemid 24141701)
119. Cutting J. The psychology of schizophrenia. London, UK.:Churchill Livingstone 1985.
120. Pfohl B, Winokur G. The micropsychopathology of hebephrenic/ catatonic schizophrenia. J Nerv Ment Dis 1983; 171:296-300.
121. Dalkin T, Murphy P, Glazebrook C, Medley I, Harrison G. Premorbid personality in first-onset psychosis. Br J Psychiatry 1994; 164(2): 202-7. (Pubitemid 24077355)
122. Bogren M, Mattisson C, Tambs K, et al. Predictors of psychosis: a 50-year follow-up of the Lundby population. Eur Arch Psychiatry Clin Neurosci 2010; 260(2): 113-25.
123. Aleman A, Kahn RS, Selten JP. Sex differences in the risk of schizophrenia: evidence from meta-analysis. Arch Gen Psychiatry 2003; 60(6): 565-71. (Pubitemid 36682313)
124. Crow TJ. The "big bang" theory of the origin of psychosis and the faculty of language. Schizophr Res 2008; 102(1-3): 31-52.
125. James A, Crow YJ, Renowden S, et al. Is the course of brain development in schizophrenia delayed? Evidence from onsets I adolescence. Schizophr Res 1999; 40(1): 1-10. (Pubitemid 29460018)
126. Bertelsen M, Jeppesen P, Petersen L, et al. Course of illness in a sample of 265 patients with first-episode psychosis - five-year follow- up of the Danish OPUS trial. Schizophr Res 2009; 107(2-3): 173-8.
127. Riecher-Rossler A, Hafner H. Schizophrenia and oestrogens-is there an association? Eur Arch Psychiatry Clin Neurosci 1993; 242(6): 323-8.
128. Grigoriadis S, Seeman MV. The role of estrogen in schizophrenia: implications for schizophrenia practice guidelines for women. Can J Psychiatry 2002; 47(5): 437-42. (Pubitemid 34792990)
129. Cohen A, Patel V. Questioning an axiom: better prognosis for schizophrenia in the developing world? Schizophr Bull 2008; 34(2): 229-44. (Pubitemid 351323326)
130. Alem A, Kebede D. Conducting psychiatric research in the developing world: Challenges and rewards. Br J Psychiatry 2003; 182: 185-7. (Pubitemid 36286726)
131. Morrison G, O'Carroll R, McCreadie R. Long-term course of cognitive impairment in schizophrenia. Br J Psychiatry 2006; 189: 556-7. (Pubitemid 44876876)
132. Gold S, Arndt S, Nopoulos P, O'Leary DS, Andreasen NC. Longitudinal study of cognitive function in first-episode and recent-onset schizophrenia. Am J Psychiatry 1999; 156(9): 1342-8. (Pubitemid 29416529)
133. Hoff AL, Svetina C, Shields G, Stewart J, DeLisi LE. Ten year longitudinal study of neuropsycological functioning subsequent to a first episode of schizophrenia. Schizophr Res 2005; 78(1): 27-34. (Pubitemid 41188322)
134. vanWinkel R, Myin-Germeys I, Delespaul P, et al. Premorbid IQ as a predictor for the course of IQ in first onset patients with schizophrenia: a 10-year follow-up study. Schizophr Res 2006; 88(1-3): 47-54. (Pubitemid 44693234)
135. Hardoy MC, Carta MG, Catena M, et al. Impairment in visual and spatial perception in schizophrenia and delusional disorder. Psychiatry Res 2004; 127(1-2): 163-6. (Pubitemid 38916877)
136. Reichenberg A, Caspi A, Harrington H, et al. Static and dynamic deficits in childhood preceding adult schizophrenia: a 30-year study. Am J Psychiatry 2010; 167(2): 160-9.
137. Aylward E, Walker E, Bettes B. Intelligence in schizophrenia: meta-analysis of the research. Schizophr Bull 1984; 10: 430-59.
138. Woodberry KA, Giuliano AJ, SeidmanLJ. Premorbid IQ in schizophrenia: a meta-analytic review. Am J Psychiatry 2008; 165: 579-87. (Pubitemid 351705334)
139. Seidman LJ, Buka SL, Goldstein JM, Tsuang MT. Intellectual decline in schizophrenia: evidence from a prospective birth cohort 28 years follow-up study. J Clin Exp Neuropsychol 2006; 28: 225-42. (Pubitemid 43254516)
140. Heaton RK, Gladsjo JA, Palmer BW, et al. The stability and course of neuropsychological deficits in schizophrenia. Arch Gen Psychiatry 2001; 58: 24-32. (Pubitemid 32057762)
141. Rund BR. A review of longitudinal studies of cognitive functions in schizophrenia patients. Schizophr Bull 1998; 24: 425-35. (Pubitemid 28378227)
142. Kurtz MM. Neurocognitive impairment across the lifespan in schizophrenia: an update. Schizophr Res 2005; 74: 15-26. (Pubitemid 40203180)
143. White L, Friedman JI, Bowie CR, et al. Long term outcomes in chronically hospitalized geriatric patients with schizophrenia: retrospective comparison of first and second generation antipsychotics. Schizophr Res 2006; 88: 127-34. (Pubitemid 44693236)
144. Rajji TK, Mulsant BH. Nature and course of cognitive functions in late-life schizophrenia: a systematic review. Schizophr Res 2008; 102: 122-140.
145. Keefe RSE, Mohs RC, Losonczy MF, et al. Characteristics of very poor outcome schizophrenia. Am J Psychiat 1987; 144: 889-95. (Pubitemid 17095726)
146. Keefe RSE, Freska E, Apter SH, et al. Clinical characteristics of Kraepelinian schizophrenia: Replication and extension of previous findings. Am J Psychiatry 1996; 153: 806-11. (Pubitemid 26170543)
147. Keefe RSE, Mohs RC, Silverman JM, et al. Characteristics of Kraepelinian schizophrenia and their relation to premorbid sociosexual functioning. In: Angrist B, Schulz SC, Eds. The neuroleptic nonresponsive patients: Characterization and treatment. Washington DC: American Psychiatric Press 1990.
148. Bralet MC, Loas G, Yon V, Marechal V. Clinical characteristics and risk factors for Kraepelinian subtype of schizophrenia: Replication of previous findings and relation to summer birth. Psychiatry Res 2002; 111: 147-54.
149. Kilzieh N, Wood AE, Erdman J, Raskind M, Tapp A. Depression in Kraepelinian schizophrenia. Compr Psychiatry 2003; 44: 1-6. (Pubitemid 36056767)
150. Brickman AM, Buchsbaum MS, Shihabuddin L, et al. Thalamus size and outcome in schizophrenia. Schizophr Res 2004; 71: 473-84. (Pubitemid 39330525)
151. Friedman JI, Harvey PD, Kemether E, Byne W, Davis KL. Cognitive and functional changes with aging in schizophrenia. Biol Psychiatry 1999; 46: 921-8. (Pubitemid 29452983)
152. Harvey PD, Reichenberg A, Bowie CR, Patterson TC, Heaton RK. The course of neuropsychological performance and functional capacity in older patients with schizophrenia. Influences of previous history of long-term institutional stay. Biol Psychiat 2010; 67: 933-9.
153. Keefe R, Bilder RM, Davis SM, et al. Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial. Arch Gen Psychiatry 2007; 64: 633-47. (Pubitemid 46878665)
154. De GraciaDòminguez M, Viechtbauer W, Simons CJ, Van Os J, Krabbendam L. Are psychotic psychopathology and neurocognition orthogonal? A systematic review of their associations. Psychol Bull 2009; 135: 157-71.
155. Palmer BW, Heaton RK, Paulsen JS, et al. Is it possible to be schizophrenic yet neuropsychologically normal? Neuropsychology 1997; 11: 437-46. (Pubitemid 27294667)
156. Kremen WS, Seidman LJ, Faraone SV, Toomey R, Tsuang MT. The paradox of normal neuropsychological function in schizophrenia. J Abnorm Psychol 2000; 109: 743-52. (Pubitemid 32096236)
157. Leung WW, Bowie CR, Harvey PD. Functional implication of neuropsychological normality and symptom remission in older outpatients diagnosed with schizophrenia: a cross-sectional study. J Int Neuropsychol Soc 2008; 14: 479-88. (Pubitemid 351560443)
158. Heinrichs RW, Miles AA, Smith D, et al. Cognitive, clinical, and functional characteristics of verbally superior schizophrenia patients. Neuropsychology 2008; 22: 321-8. (Pubitemid 351645172)
159. Palmer BW, Heaton RK, Gladsjo JA, et al. Heterogeneity in functional status among older outpatients with schizophrenia: employment history, living situation, and driving. Schizophr Res 2002; 55: 205-15. (Pubitemid 34607375)
160. Wykes T, Huddy V, Cellard C, McGurk SR, Czobor P. A metaanalysis of cognitive remediation for schizophrenia: methodology and effect sizes. Am J Psychiatry 2011; 168: 472-85.
161. McGurk SR, Twamley EW, Sitzer DI, McHugo GJ, Mueser KT. A meta-analysis of cognitive remediation in schizophrenia. Am J Psychiatry 2007; 164: 1791-802. (Pubitemid 351739231)
162. Kurtz MM, Moberg PJ, Gur RC, Gur RE. Approaches to cognitive remediation of neuropsychological deficits in schizophrenia: a review and meta-analysis. Neuropsychol Rev 2001; 11: 197-210. (Pubitemid 33744613)
163. Keshavan MS, Eack SM, Wojtalik JA, et al. A broad cortical reserve accelerates response to cognitive enhancement therapy in early course schizophrenia. Schizophr Res 2011; 130: 123-9.
164. Veltro F, Mazza M, Vendittelli N, et al. A comparison of the effectiveness of Problem Solving Training and of Cognitive-Emotional Rehabilitation on neurocognition, social cognition and social functioning in people with schizophrenia. Clin Pract Epidemiol Ment Health 2011; 7: 123-32.
165. Suresh Kumar PN. Impact of vocational rehabilitation on social functioning, cognitive functioning, and psychopathology in patients with chronic schizophrenia. Indian J Psychiatry 2008; 50: 257-61.
166. Weng YZ, Xiang YQ, Liberman RP. Psychiatric rehabilitation in a Chinese psychiatric hospital. Psychiatr Serv 2005; 56: 401-3. (Pubitemid 40471579)
167. Rusch N, Corrigan PW, Wassel A, et al. A stress coping model of mental illness stigma: I. Predictors of cognitive stress appraisal. Schizophr Res 2009; 110: 59-64.
168. Pantelis C, Velakoulis D, Wood SJ, et al. Neuroimaging and emerging psychotic disorders: the Melbourne ultra-risk studies. Int Rev Psychiatry 2007; 19: 371-81.
169. Mitelman SA, Buchsbaum MS. Very poor outcome schizophrenia: Clinical and
170. Chow EW, Ho A, Wei C, et al. Association of schizophrenia in 22q11.2 deletion syndrome and grey matter volumetric deficits in the superior temporal gyrus. Am J Psychiatry 2011; 168: 522-9.
171. Gur RE, Gur RC. Functional magnetic resonance imaging in schizophrenia. Dialogues Clin Neurosci 2010; 12: 333-43. Review.
172. Brown GG, Thompson WK. Functional brain imaging in schizophrenia: selected results and methods. Curr Top Behav Neurosci 2010; 4: 181-214. Review.